商业化
3D打印
医药制造业
3d打印
制造工程
药剂学
计算机科学
业务
工程类
医学
药理学
营销
机械工程
作者
Shanshan Wang,Xuejun Chen,Xiaolu Han,Xiaoxuan Hong,Xiang Li,Hui Zhang,Meng Li,Zengming Wang,Aiping Zheng
出处
期刊:Pharmaceutics
[Multidisciplinary Digital Publishing Institute]
日期:2023-01-26
卷期号:15 (2): 416-416
被引量:124
标识
DOI:10.3390/pharmaceutics15020416
摘要
Three-dimensional printing technology, also called additive manufacturing technology, is used to prepare personalized 3D-printed drugs through computer-aided model design. In recent years, the use of 3D printing technology in the pharmaceutical field has become increasingly sophisticated. In addition to the successful commercialization of Spritam® in 2015, there has been a succession of Triastek’s 3D-printed drug applications that have received investigational new drug (IND) approval from the Food and Drug Administration (FDA). Compared with traditional drug preparation processes, 3D printing technology has significant advantages in personalized drug manufacturing, allowing easy manufacturing of preparations with complex structures or drug release behaviors and rapid manufacturing of small batches of drugs. This review summaries the mechanisms of the most commonly used 3D printing technologies, describes their characteristics, advantages, disadvantages, and applications in the pharmaceutical industry, analyzes the progress of global commercialization of 3D printed drugs and their problems and challenges, reflects the development trends of the 3D printed drug industry, and guides researchers engaged in 3D printed drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI